News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

March 2015

Top

EU recommends Roche’s Avastin plus chemotherapy to treat cervical cancer
02 March 2015 The European Union's (EU) Committee for Medicinal Products for Human Use (CHMP) has recommended the use of Avastin (bevacizumab) in combination with standard chemotherapy (paclitaxel and...

Mylan acquires Abbott’s non-US specialty and branded generics business
02 March 2015 Mylan has completed the acquisition of non-US developed markets specialty and branded generics business from Abbott Laboratories, in an all-stock transaction valued at...

February 2015

Top

EMA accepts Amgen’s MAA for Kyprolis to treat multiple myeloma
27 February 2015 The European Medicines Agency (EMA) has accepted US-based drugmaker Amgen's marketing authorisation application (MAA) for Kyprolis (carfilzomib) for Injection to treat patients with...

Amarin and Eddingpharm partner to develop and market Vascepa in China
27 February 2015 Amarin has signed an exclusive agreement with Eddingpharm to develop and commercialise Vascepa (icosapent ethyl) in mainland China, Hong Kong and the Macao Special Administrative Regions and Taiwan....

Sanofi's diabetes treatment Toujeo obtains FDA approval
26 February 2015 Sanofi has received approval from the US Food and Drug Administration (FDA) for its Toujeo (insulin glargine [rDNA origin] injection, 300U/mL)....

AstraZeneca and Orca partner to develop inhibitors for autoimmune diseases
26 February 2015 Orca Pharmaceuticals has signed a three-year collaboration agreement with AstraZeneca to develop inhibitors of retinoic acid-related orphan nuclear receptor gamma (ROR γ)....

Merck and MPP partner to supply paediatric HIV drug in developing nations
25 February 2015 US-based pharmaceutical firm Merck has entered an agreement with the Medicines Patent Pool (MPP) to provide its paediatric formulations of raltegravir to treat HIV-1 infection in infants...

Shire buys US-based Meritage Pharma for $70m
25 February 2015 Irish drug-maker Shire has acquired US-based privately held company Meritage Pharma for around $70m....

BMS to acquire biotechnology firm Flexus for $1.25bn
24 February 2015 Bristol-Myers Squibb (BMS) has entered an agreement to acquire biotechnology firm Flexus Biosciences for around $1.25bn....

Novartis’s Farydak obtains FDA approval to treat multiple myeloma
24 February 2015 Novartis has received approval from the US Food and Drug Administration (FDA) for its Farydak (panobinostat or earlier known as LBH589) capsules in combination with bortezomib and dexamethasone...

Japanese firm Sosei buys UK’s Heptares Therapeutics for $400m
23 February 2015 Japanese firm Sosei Group has acquired UK-based biotechnology company Heptares Therapeutics, in a deal valued at $400m....

Valeant to buy US-based Salix for $14.5bn
23 February 2015 Canada-based Valeant Pharmaceuticals International has signed an agreement to acquire US-based Salix Pharmaceuticals, for around $14.5bn....

Celgene's Revlimid receives FDA approval to treat NDMM
20 February 2015 Celgene has received approval from the US Food and Drug Administration (FDA) to expand the existing indication for Revlimid (lenalidomide) in combination with dexamethasone to include...

Crohn's disease Remsima could save up to €336m over five years, says Celltrion
20 February 2015 The EMA-approved biosimilar monoclonal antibody Remsima, developed for Crohn's disease (CD), is likely to result in savings ranging from €76m to €336m over five years across, according to...

aTyr Pharma’s Resolaris obtains EMA orphan drug designation to treat FSHD
19 February 2015 Biotherapeutics firm aTyr Pharma has received orphan drug designation from the European Commission (EC) for its Resolaris to treat facioscapulohumeral muscular dystrophy (FSHD)....

Sanofi and Lead Pharma to develop treatments for autoimmune diseases
19 February 2015 France-based Sanofi has partnered with Dutch biotech firm Lead Pharma to discover, develop and commercialise treatments for autoimmune diseases....

Lupin and Celon Pharma partner for generic version of GSK’s Advair Diskus
18 February 2015 India-based drugmaker Lupin has signed an agreement with Polish biopharmaceutical firm Celon Pharma to develop a fluticasone / salmeterol dry powder inhaler (DPI)....

Teva to commercialise Eagle's cancer drug in US
18 February 2015 Israel-based Teva Pharmaceutical Industries has signed an exclusive licence agreement with Eagle Pharmaceuticals for its bendamustine hydrochloride (HCl) rapid infusion product....

Hospira introduces its biosimilar mAb Inflectra in major European markets
17 February 2015 US-based pharmaceutical firm Hospira has introduced its first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), in major European markets....

Alzheimer's Research UK launches three new drug discovery institutes
17 February 2015 Alzheimer's Research UK has launched three new drug discovery institutes at Cambridge and Oxford universities and University College London (UCL). ...

TPG to acquire Actavis’s Pharmatech
16 February 2015 Private investment firm TPG has signed an agreement with Ireland-based Actavis to acquire its Aptalis Pharmaceutical Technologies (Pharmatech)....